Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P682: GO-CARE: a prospective multi-centre observational study of golimumab effectiveness and quality of life in a real life UC patient population in Italy

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Armuzzi1, A. Gasbarrini2, S. Marchi3, S. Saibeni4, V. Germano*5, S. Cercone5, F. Bossa7, A. C. Privitera8

1IBD Unit, Presidio Columbus, Fondazione Policlinico Gemelli Università Cattolica, Rome, Italy, 2Internal Medicine, Gastroenterology and Liver Unit, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy, 3Division of Gastroenterology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy, 4Gastroenterology Unit, RhoHospital, Rho, Italy, 5MSD Italia, Rome, Italy, 7Division of Gastroenterology, Casa Sollievo della Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Foggia, Italy, 8IBD and Pelvic Floor Unit, Azienda Ospedaliera per l'Emergenza, Ospedale Cannizzaro, Catania, Italy

P683: Higher serum golimumab concentrations are significantly associated with combined clinical-biochemical remission during maintenance therapy: results from the GO-LEVEL study

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Samaan*1, G. Cunningham1, A. G. Tamilarasan1, K. Rawstron2, K. Hawash2, L. Beltran2, I. Koumoutsos1, S. Ray1, J. Mawdsley1, S. Anderson1, J. Sanderson1, Z. Arkir2, P. Irving1

1Guy's & St Thomas' Hospital, Gastroenterology, London, UK, 2Guy's & St Thomas' Hospital, Viapath Laboratories, London, UK

P684: Vaccination strategies for IBD patients

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Sitibondo*1, A. Squeri1, A. Viola1, G. Costantino1, A. Belvedere1, V. Pisana1, F. Costa2, R. Squeri2, W. Fries1

1AOU G. Martino, Department of Clinical and Experimental Medicine, IBD Unit, University of Messina, Messina, Italy, 2AOU G. Martino, Vaccination Centre, Department of Biomedical Sciences and Morphological and Functional Imaging, University of Messina, Messina, Italy

P685: Improvement in patient-reported Inflammatory Bowel Disease Questionnaire outcomes, and relationship with disease activity, in tofacitinib-treated patients with ulcerative colitis: Data from the OCTAVE clinical trials

ECCO '19 Copenhagen

Year: 2019
Authors:

M. C. Dubinsky1, B. Bressler2, A. Armuzzi*3, L. Salese4, M. DiBonaventura5, E. Maller4, H. Fan4, D. A. Woodworth4, C. Su4

1Icahn School of Medicine at Mount Sinai Hospital, Department of Pediatrics and Medicine, New York, NY, USA, 2University of British Columbia, Division of Gastroenterology, Department of Medicine, Vancouver, BC, Canada, 3Presidio Columbus Fondazione Policlinico A. Gemelli IRCCS – Università Cattolica del Sacro Cuore, IBD Unit, Rome, Italy, 4Pfizer Inc., Collegeville, PA, USA, 5Pfizer Inc., New York, NY, USA

P686: Neither high infliximab maintenance doses nor high trough levels trigger skin side effects of the drug: a prospective cross-sectional study

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Kurent*1, U. Koren2, J. Hanzel1, M. Kozelj1, G. Novak1, N. Smrekar1, B. Stabuc1, N. Kecelj3, D. Drobne1

1University Medical Centre Ljubljana, Department of Gastroenterology, Ljubljana, Slovenia, 2University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia, 3University Medical Centre Ljubljana, Department of Dermatology, Ljubljana, Slovenia

P687: Clinical remission demonstrated with oral ozanimod in the overall population and across multiple subgroups of patients with moderately to severely active ulcerative colitis in the TOUCHSTONE trial

ECCO '19 Copenhagen

Year: 2019
Authors:

B. G. Feagan*1, W. J. Sandborn2, G. D'Haens3, S. Hanauer4, D. C. Wolf5, S. Vermeire6, S. Ghosh7, A. Petersen8, S. Y. Hua8, K. Shan8, J. Liu8

1Robarts Clinical Trials, Western University, London, Canada, 2University of California - San Diego, San Diego, USA, 3Academic Medical Center, Amsterdam, The Netherlands, 4Feinberg School of Medicine, Chicago, USA, 5Atlanta Gastroenterology Associates, Atlanta, USA, 6University of Leuven, Leuven, Belgium, 7University of Calgary, Calgary, Canada, 8Celgene Corporation, Summit, USA

P688: Ustekinumab in resistant Crohn’s disease: 1-year UK IBD tertiary referral centre ‘real-world’ experience

ECCO '19 Copenhagen

Year: 2019
Authors:

S. P. Borg-Bartolo*1, K. Kemp1, R. P. Willert1, A. J. Makin1, S. E. Levison1

1Manchester University NHS Foundation Trust, Department of Gastroenterology, Manchester, UK

P689: The effect of nutritional therapy on bone mineral density and bone metabolism in paediatric Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Lev-Tzion*1, T. Ben-Moshe1, G. Abitbol1, O. Ledder1,2, A. Levine3,4, S. Peleg5,6, P. Millman7, R. Shaoul6,8, H. Shamaly9, A. On10,11, M. Kori2,12, A. Assa13,14, S. Cohen4,15, E. Broide4,16, D. Turner1,2

1Shaare Zedek Medical Center, Jerusalem, Israel, 2The Hebrew University of Jerusalem, Jerusalem, Israel, 3Edith Wolfson Medical Center, Holon, Israel, 4Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, 5Ha'Emek Medical Center, Afula, Israel, 6The Ruth and Bruce Rappaport School of Medicine, Technion - Israel Institute of Technology, Haifa, Israel, 7Hadassah-Hebrew University Medical Center, Jerusalem, Israel, 8Rambam Medical Center, Haifa, Israel, 9French Hospital, Nazareth, Israel, 10Baruch Padeh Medical Center, Poriya, Israel, 11Bar-Ilan University, Galille, Israel, 12Kaplan Medical Center, Rehovot, Israel, 13Schneider Children's Medical Center, Petach Tikva, Israel, 14Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel, 15Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 16Assaf Harofeh Medical Center, Zerifin, Israel

P690: Comparative efficacy of vedolizumab and adalimumab as second-line therapy in ulcerative colitis patients previously treated with infliximab

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Favale1, S. Onali*1, F. Caprioli2, D. Pugliese3, A. Armuzzi3, F. S. Macaluso4, A. Orlando4, A. Viola5, W. Fries5, G. Mocci6, F. Chicco7, P. Usai7, A. Rispo8, F. Castiglione8, E. Calabrese1, L. Biancone1, G. Monteleone1, M. C. Fantini1

1Università degli studi di Roma, Tor Vergata, Roma, Italy, 2Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Università degli studi di Milano, Milano, Italy, 3Fondazione Policlinico Universitario Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy, 4Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy, 5Università degli studi di Messina, Messina, Italy, 6Azienda Ospedaliera Brotzu, Cagliari, Italy, 7Università degli studi di Cagliari, Cagliari, Italy, 8Università Federico II di Napoli, Napoli, Italy

P691: Trends in diagnostic prevalence and treatment patterns of adult ulcerative colitis patients in the USA, 2007–2017

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Hunter*1, A. Naegeli1, Y. Dong1, C. Choong1, D. Stefani-Hunyady1

1Eli Lilly and Company, Indianapolis, USA

P692: Positive histological margins is a risk factor of recurrence after ileocaecal resection in Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Riault*1, M. Diouf2, D. Chatelain2, J. p. Le Mouel1, J. Loreau1, J. Turpin1, C. Yzet1, F. Brazier1, C. Sabbagh2, J. l. Dupas1, E. Nguyen-Khac1, M. Fumery1

1Amiens University Hospital, Gastro-enterology, Amiens, France, 2Amiens University Hospital, Amiens, France

P693: Vedolizumab treatment for pouch inflammation

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Hirsch*1, H. Tulchinsky2, N. Maharshak1

1Tel Aviv Medical Center, Gastroenterology and liver diseases, Tel Aviv, Israel, 2Tel Aviv Medical Center, Department of Surgery, Tel Aviv, Israel

P694: Genetic predisposition and thiopurine-induced pancreatitis in inflammatory bowel disease patients

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Burnet*1, N. de Suray2, B. De Vroey3, P. Hoang4, J-C. Coche5, M. Denis1, J-L. Gala6, O. Dewit1

1Cliniques Universitaires St-Luc, Gastroenterology, Brussels, Belgium, 2Grand Hôpital de Charleroi, Gastroenterology, Charleroi, Belgium, 3Centres Hospitaliers Jolimont, Gastroenterology, Haine-Saint-Paul, Belgium, 4Clinique Sainte-Elisabeth, Gastroenterology, Namur, Belgium, 5Clinique St Pierre, Gastroenterology, Ottignies, Belgium, 6Université Catholique de Louvain, Centre de Technologies Moléculaires Appliquées, Institut de Recherche Expérimentale et Clinique, Brussels, Belgium

P695: Feasibility and safety of strictureplasties performed by laparoscopic approach for complicated Crohn’s disease: A prospective observational cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

G. M. Sampietro1, F. Colombo*1, A. Frontali2, C. Baldi1, L. Conti1, D. Dilillo3, P. Fiorina4, G. Maconi5, S. Ardizzone5, F. Corsi6, G. Zuccotti3, D. Foschi1

1Luigi Sacco University Hospital, General Surgery, Milano, Italy, 2Hôpiteau de Paris (AP-HP), Beaujon Hospital, University Denis Diderot, Department of Colorectal Surgery, Pôle des Maladies de l'Appareil Digestif (PMAD), Paris, France, 3Luigi Sacco University Hospital, Division of Pediatrics, Milano, Italy, 4Luigi Sacco University Hospital, Division of Endocrinology, Milano, Italy, 5Luigi Sacco University Hospital, Gastroenterology, Milano, Italy, 6ICS Maugeri, General Surgery Department, Pavia, Italy

P696: Long-term prognosis and predictive factors for surgical treatment of intestinal lesions in patients with Behcet’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Chohno*1, K. Watanabe1, T. Minagawa1, R. Kuwahara1, Y. Horio1, H. Sasaki1, T. Bando1, M. Uchino1, H. Ikeuchi1

1Hyogo College of Medicine, Inflammatory Bowel Disease, Nishinomiya, Hyogo, Japan

P697: Pneumocystis jirovecii pneumonia in IBD patients treated with immunomodulator(s)

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Vieujean*1, A. Moens2, K. Rothfuss3, E. Savarino4, S. Vavricka5, C. Reenaers1, M. Ferrante2, J-F. Rahier6, ECCO CONFER Investigators1

1University Hospital of Liège, Department of Gastroenterology, Liège, Belgium, 2University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium, 3Robert-Bosch-Hospital, Department of Gastroenterology and Hepatology, Stuttgart, Germany, 4University of Padua, Department of Gastroenterology, Padua, Italy, 5University Hospital, Department of Gastroenterology and Hepatology, Zurich, Switzerland, 6CHU UCL Namur, Department of Gastroenterology and Hepatology, Yvoir, Belgium

P698: Persistence, clinical effectiveness and safety of vedolizumab in the post-marketing real clinical practice in Italy: a double-centre, 2-year experience in Crohn’s disease and ulcerative colitis patients

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Sartini*1, R. Solimando2, A. Curatolo1, M. C. Verga1, A. Bertani1, M. Di Girolamo3, A. Merighi2, E. Villa1

1Struttura Complessa di Gastroenterologia Azienda Ospedaliero - Universitaria di Modena, Policlinico, Modena, Italy, 2Gastroenterologia Azienda Ospedaliero-Universitaria di Ferrara, Arcispedale Sant'Anna, Ferrara, Italy, 3Azienda USL Modena, Modena, Italy

P699: Faecal microbiota transplantation as treatment for recurrent clostridium difficile infections: a single-centre experience

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Caenepeel*1, A. Schroë1, K. Van den Broeck2, M. Ferrante1,2, S. Vermeire1,2

1KU Leuven, TARGID, Leuven, Belgium, 2University hospitals Leuven, Gastroenterology and Hepatology, Leuven, Belgium

P700: The efficacy of colesevelam to treat bile acid malabsorption in Crohn's disease: data from TOPPIC trial

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Devarakonda*1, I. Arnott2, J. Satsangi3

1The University of Edinburgh, Gastroenterology, Edinburgh, UK, 2Western General Hospital, Gastroenterology, Edinburgh, UK, 3University of Edinburgh, Edinburgh, UK

P701: The comparative safety of different intravenous iron preparations in inflammatory bowel disease: a systematic review and network meta-analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Aksan*1,2, H. Işık2, K. Farrag1,3, A. Dignass4, J. Stein1,3

1Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 2Hacettepe University, Ankara, Turkey, 3DGD Clinics Sachsenhausen, Frankfurt/Main, Germany, 4Agaplesion Markuskrankenhaus, Frankfurt/Main, Germany